162 related articles for article (PubMed ID: 2479772)
1. Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.
Murdin AD; Wimmer E
J Virol; 1989 Dec; 63(12):5251-7. PubMed ID: 2479772
[TBL] [Abstract][Full Text] [Related]
2. Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.
Murray MG; Kuhn RJ; Arita M; Kawamura N; Nomoto A; Wimmer E
Proc Natl Acad Sci U S A; 1988 May; 85(9):3203-7. PubMed ID: 2834736
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
Altmeyer R; Murdin AD; Harber JJ; Wimmer E
Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
[TBL] [Abstract][Full Text] [Related]
4. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.
Martin A; Wychowski C; Couderc T; Crainic R; Hogle J; Girard M
EMBO J; 1988 Sep; 7(9):2839-47. PubMed ID: 2460345
[TBL] [Abstract][Full Text] [Related]
5. Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.
Delpeyroux F; Van Wezel E; Blondel B; Crainic R
J Virol; 1990 Dec; 64(12):6090-100. PubMed ID: 2173781
[TBL] [Abstract][Full Text] [Related]
6. The effect of site and mode of expression of a heterologous antigenic determinant on the properties of poliovirus hybrids.
Murdin AD; Mirzayan C; Kameda A; Wimmer E
Microb Pathog; 1991 Jan; 10(1):27-37. PubMed ID: 1713280
[TBL] [Abstract][Full Text] [Related]
7. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
8. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.
Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R
J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus antigenic hybrids simultaneously expressing antigenic determinants from all three serotypes.
Murdin AD; Lu HH; Murray MG; Wimmer E
J Gen Virol; 1992 Mar; 73 ( Pt 3)():607-11. PubMed ID: 1372037
[TBL] [Abstract][Full Text] [Related]
10. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
Harber J; Bernhardt G; Lu HH; Sgro JY; Wimmer E
Virology; 1995 Dec; 214(2):559-70. PubMed ID: 8553558
[TBL] [Abstract][Full Text] [Related]
11. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
Dai C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
[TBL] [Abstract][Full Text] [Related]
12. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
13. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
[TBL] [Abstract][Full Text] [Related]
14. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.
Yakovenko ML; Cherkasova EA; Rezapkin GV; Ivanova OE; Ivanov AP; Eremeeva TP; Baykova OY; Chumakov KM; Agol VI
J Virol; 2006 Mar; 80(6):2641-53. PubMed ID: 16501074
[TBL] [Abstract][Full Text] [Related]
15. Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4.
Minor PD; Ferguson M; Katrak K; Wood D; John A; Howlett J; Dunn G; Burke K; Almond JW
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2475-81. PubMed ID: 1717641
[TBL] [Abstract][Full Text] [Related]
16. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.
Murray MG; Bradley J; Yang XF; Wimmer E; Moss EG; Racaniello VR
Science; 1988 Jul; 241(4862):213-5. PubMed ID: 2838906
[TBL] [Abstract][Full Text] [Related]
17. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
18. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
[TBL] [Abstract][Full Text] [Related]
19. A cassette vector for the construction of antigen chimaeras of poliovirus.
Burke KL; Evans DJ; Jenkins O; Meredith J; D'Souza ED; Almond JW
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2475-9. PubMed ID: 2476528
[TBL] [Abstract][Full Text] [Related]
20. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
Reynolds C; Page G; Zhou H; Chow M
Virology; 1991 Sep; 184(1):391-6. PubMed ID: 1714663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
